Position in ADMA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$566,222
-$122,087 QoQ
Shares Held
67,649
-11.4% QoQ
Ownership
0.030%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
#134
of 321 holders
Holding Since
Sep 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADMA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Morse Asset Management, Inc holds $10,205,191 across 7 Biotechnology names. ADMA ranks #4 (5.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
10,526 | $5,228,579 | |
| 2 | ASND |
Ascendis Pharma A/S
|
9,589 | $2,557,578 | |
| 3 | ARGX |
Argenx SE
|
1,348 | $1,250,633 | |
| 4 | ADMA |
Adma Biologics, Inc.
This page
|
67,649 | $566,222 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
1,378 | $392,688 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
334 | $208,262 | |
| 7 | MANE |
Veradermics, Inc
|
10 | $1,229 |
All Filings in ADMA
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $566,222 | 67,649 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $688,309 | 76,394 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $44,323 | 2,430 | Shares | Sole | 2026-02-03 | |
| 2025-06-30 | $801,403 | 44,009 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $172,608 | 8,700 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $125,195 | 7,300 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $4,497 | 225 | Shares | Sole | 2024-11-20 | |
| No filing history on record for this holder in this stock. | ||||||